Effective high-dose clonazepam treatment in two patients with opsoclonus and myoclonus: GABAergic hypothesis [3]

European Neurology

Volumn 56, Issue 4, 2006, Pages 240-242

  Bartoš, Aleš ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ACICLOVIR; CARBAMAZEPINE; CLONAZEPAM; GABAPENTIN; IMMUNOGLOBULIN; LAMOTRIGINE; METHYLPREDNISOLONE; PIRACETAM; PREDNISONE; STEROID; THIAMINE; TIAPRIDE;

ADULT; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RECEPTOR BINDING; GABAERGIC SYSTEM; HUMAN; LETTER; MYOCLONUS; NEUROLOGIC DISEASE; NEUROTRANSMISSION; OPSOCLONUS; PATHOGENESIS; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; ANTICONVULSANTS; BRAIN; CLONAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-AMINOBUTYRIC ACID; HUMANS; OPSOCLONUS-MYOCLONUS SYNDROME;

EID: 33845640410     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096494     Document Type: Letter

References (12)

1. Pranzatelli MR: The neurobiology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 1992;15:186-228.
2. Pranzatelli MR: The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 1996;19:1-47.
3. Glatz K, Meinck HM, Wildemann B: Parainfectious opsoclonus-myoclonus syndrome: high-dose intravenous immunoglobulins are effective. J Neurol Neurosurg Psychiatry 2003;74:279-280.
4. Oguro K, Kobayashi J, Aiba H, Hojo H: Opsoclonus-myoclonus syndrome with abnormal single photon emission computed tomography imaging. Pediatr Neurol 1997;16:334-336.
5. Bartos A, Pitha J: Opsoclonus-myoclonusdysequilibrium syndrome: cytological and immunological dynamics in the serial cerebrospinal fluid in two patients. J Neurol 2003;250:1420-1425.
6. Helmchen C, Rambold H, Sprenger A, Erdmann C, Binkofski F: Cerebellar activation in opsoclonus: an fMRI study. Neurology 2003;61:412-415.
7. Anderson NE, Budde-Steffen C, Rosenblum MK, Graus F, Ford D, Synek BJ, Posner JB: Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine (Baltimore) 1988;67:100-109.
8. Caviness JN, Forsyth PA, Layton DD, McPhee TJ: The movement disorder of adult opsoclonus. Mov Disord 1995;10:22-27.
9. Straube A, Leigh RJ, Bronstein A, Heide W, Riordan-Eva P, Tijssen CC, Dehaene I, Straumann D: EFNS task force - therapy of nystagmus and oscillopsia. Eur J Neurol 2004;11:83-89.
10. Klempir J, Vymetalova P, Ulmanova L, Roth J: Syndrom opsoklonus- myoklonus: přehled a kazuistika [Opsoclonus - myoclonus syndrome: a review and a case report]. Ces A Slov Neurol Neurochir 2004;67/100:137-140.
11. Tanaka C, Bowery NG: GABA: Receptors, Transporters and Metabolism. Basel, Birkhäuser, 1996.
12. Moretti R, Torre P, Antonello RM, Nasuelli D, Cazzato G: Opsoclonus-myoclonus syndrome: gabapentin as a new therapeutic proposal. Eur J Neurol 2000;7:455-456.